Copper Enhances Amyloid-β Peptide Neurotoxicity and non β-Aggregation: A Series of Experiments Conducted upon Copper-Bound and Copper-Free Amyloid-β Peptide
Copper Enhances Amyloid-β Peptide Neurotoxicity and non β-Aggregation: A Series of Experiments Conducted upon Copper-Bound and Copper-Free Amyloid-β Peptide
复制标题
DOI:
10.1007/s12031-009-9282-8
复制
发表时间:
2010-05-01
影响因子:
3.1
通讯作者:
Jiang, Zhaofeng
中科院分区:
文献类型:
--
作者:
Dai, Xueling;Sun, Yaxuan;Jiang, Zhaofeng
Alzheimer's disease is characterized by the abnormal aggregation of amyloid-beta peptide (A beta) in extracellular deposits known as senile plaques. However, the nature of the toxic A beta species and its precise mechanism of action remain unclear. Previous reports suggest that the histidine residues are involved in copper-A beta interaction, by which resulting in the neurotoxicity of A beta and free radical damage. Here, we employed a mutant A beta (A beta H13R) in which a histidine residue was replaced by arginine. Copper facilitated the precipitation of both wild-type and mutant A beta in the spectrophotometric absorbance assay but suppressed beta-structure aggregates according to Thioflavine-T assay. Wild-type A beta alone is more cytotoxic but produced less amount of H2O2 than A beta H13R-copper complexes, suggesting that A beta-membrane interaction may also implicated in the pathologic progress. A beta toxicity is in positive correlation to its competence to aggregate despite the aggregation is mainly composed of non-beta fibril substances. In short, these findings may provide further evidence on the role of copper in the pathogenesis of Alzheimer's disease.